Duodenal jejunal bypass liner for DIABESITY - Risk Versus benefit data from the Association of British Clinical Diabetologists (ABCD) Worldwide Endobarrier Registry.
Authors:
B. Ryder, M. Lynne, H. Frydenberg, S. Fishman, R. Cohen, C. de Jonge, J. Greve, J. Bascomb, J. Bessell, J. McMaster, G. Holtman, G. Rich, J. Collins, L. Kow, P. Pferschy, H. Sourij, J. Byrne, J. Mason, J. Teare, M. Benes.
Evaluation of the efficacy and safety of endoscopically achieved proximal intestinal exclusion as an adjunct to glucagon-like peptide-1 therapy in Diabesity: REVISE-DIABESITY randomised clinical trial.
Authors:
P. Sen Gupta, B. McGowan, R. Drummond, S. Amiel, B. Ryder.
The 2023 National Clinical Impact Awards round is now open for applications.
Applications opened on Friday 10th March and will close at 5pm on Friday 5th May 2023.
Sodium-glucose link transporter-2 inhibitors in reduced renal function: Cross-class comparison from the Association of British Clinical Diabetologists (ABCD) audits.
Authors:
TSJ Crabtree, A Bickerton, K Dhatariya, A Gallagher, J Elliott, R Raghavan, IW Gallen, REJ Ryder on behalf of all ABCD SGLT2 audit contributors.
Which DIYAPS systems and are people using in the United Kingdom? Insights from the Association of British Clinical Diabetologist’s (ABCD) DIYAPS audit programme.
Authors:
TSJ Crabtree, S Hussain, B Mendis, T Gazis, R Herring, I Idris REJ Ryder, EG Wilmot
Glycaemic and safety outcomes associated with do-it-yourself artificial pancreas systems (DIYAPS): Initial insights from the Association of British Clinical Diabetologist’s (ABCD) DIYAPS audit programme.
Authors:
TSJ Crabtree, S Hussain, B Mendis, T Gazis, R Herring, I Idris, REJ Ryder, EG Wilmot
The effect of semaglutide on alanine aminotransferase (ALT) levels: results from the Association of British Clinical Diabetologists (ABCD) nationwide audit.
Authors:
TSJ Crabtree, DK Sennik, A Bickerton, D Barnes, S Sivappriyan, K Adamson, SM Phillips, A Evans, N Larsen, A Panesar, ML Cull, IW Gallen, IR Idris, REJ Ryder on behalf of all ABCD Semaglutide audit contributors
HbA1c and weight changes with semaglutide at 6- and 12-months post commencement: Updated results from the ABCD Semaglutide audit.
Authors:
BCT Field, TSJ Crabtree, K Adamson, D Barnes, S Sivappriyan, A. Bickerton, A Gallagher, IW Gallen, I Idris, REJ Ryder; on behalf of ABCD Semaglutide audit contributors
Factors predicting achievement of recommend time-in-range at 6-months postcommencement amongst closed-loop users with elevated baseline HbA1c levels.
Authors:
TSJ Crabtree, TP Griffin, P Narendran, G Gallen, J Elliott, YW Yap, A Lumb, P Hammond, REJ Ryder, P Choudhary, EG Wilmot on behalf of all ABCD Closed-Loop Audit contributors.
